logo
Plus   Neg
Share
Email

Achieve Life Sciences (ACHV) Is Spiking Higher After Partnership Expands

Achieve Life Sciences (ACHV) announced Wednesday morning that it has agreed to amend its Technology Licence Agreement with the University of Bristol. The company has been granted exclusive rights for all human medicinal uses of cytisine derivatives created under the agreement.

Achieve Life Sciences has spiked sharply to the upside in early trade Wednesday and is currently higher by 1.20 at $2.71 on above average volume. The stock has surged to a 3-month high.

For comments and feedback contact: editorial@rttnews.com

Business News

Follow RTT